Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bardon

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
International Journal of Oncology|February 12, 1998
Retinoic acid suppresses insulin-induced cell growth and cyclin D1 gene expression in human breast cancer cellsS Bardon, L Razanamahefa
Nutrition and Cancer|November 24, 1998
Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell linesS Bardon, K Picard, P Martel
Nutrition and Cancer|August 30, 2001
Stimulatory effect of arachidonic acid on T-47D human breast cancer cell growth is associated with enhancement of cyclin D1 mRNA expressionL Razanamahefa, S Prouff, S Bardon
Cancer Research|March 1, 1987
Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cellsS Bardon, F Vignon, P Montcourrier, et al.
Cancer Letters|January 19, 1996
Metabolic conversion and growth effects of n-6 and n-3 polyunsaturated fatty acids in the T47D breast cancer cell lineS Bardon, M T Le, J M Alessandri
The Journal of Clinical Endocrinology and Metabolism|June 1, 1983
Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in cultureF Vignon, S Bardon, D Chalbos, et al.
Molecular and Cellular Endocrinology|May 1, 1984
The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptorS Bardon, F Vignon, D Derocq, et al.
Journal of Steroid Biochemistry|January 1, 1984
Steroidal and nonsteroidal antiestrogens in breast cancer cells in cultureH Rochefort, S Bardon, D Chalbos, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1985
RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptorS Bardon, F Vignon, D Chalbos, et al.
Biochemical and Biophysical Research Communications|September 30, 1992
Essential role of collagens for terminal differentiation of preadipocytesA Ibrahimi, F Bonino, S Bardon, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Oncology|February 12, 1998
Retinoic acid suppresses insulin-induced cell growth and cyclin D1 gene expression in human breast cancer cellsS Bardon, L Razanamahefa
Nutrition and Cancer|November 24, 1998
Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell linesS Bardon, K Picard, P Martel
Nutrition and Cancer|August 30, 2001
Stimulatory effect of arachidonic acid on T-47D human breast cancer cell growth is associated with enhancement of cyclin D1 mRNA expressionL Razanamahefa, S Prouff, S Bardon
Cancer Research|March 1, 1987
Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cellsS Bardon, F Vignon, P Montcourrier, et al.
Cancer Letters|January 19, 1996
Metabolic conversion and growth effects of n-6 and n-3 polyunsaturated fatty acids in the T47D breast cancer cell lineS Bardon, M T Le, J M Alessandri
The Journal of Clinical Endocrinology and Metabolism|June 1, 1983
Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in cultureF Vignon, S Bardon, D Chalbos, et al.
Molecular and Cellular Endocrinology|May 1, 1984
The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptorS Bardon, F Vignon, D Derocq, et al.
Journal of Steroid Biochemistry|January 1, 1984
Steroidal and nonsteroidal antiestrogens in breast cancer cells in cultureH Rochefort, S Bardon, D Chalbos, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1985
RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptorS Bardon, F Vignon, D Chalbos, et al.
Biochemical and Biophysical Research Communications|September 30, 1992
Essential role of collagens for terminal differentiation of preadipocytesA Ibrahimi, F Bonino, S Bardon, et al.
Pageof 2